# Pharmaceutical Specialties, Inc. – FDA Inspection, May 3, 2019

Source: https://www.keypedia.com/records/fda_inspections/pharmaceutical-specialties-inc/480a4535-0bb5-4262-841f-4eff1aa484d6
Source feed: FDA_Inspections

> FDA inspection 1091169 of Pharmaceutical Specialties, Inc., May 03, 2019. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091169
- Company Name: Pharmaceutical Specialties, Inc.
- Inspection Date: 2019-05-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1274911 - 2025-08-15](https://www.keypedia.com/records/fda_inspections/pharmaceutical-specialties-inc/2336d78e-7de4-4d30-aba2-d308c403a491)
- FDA Inspection 867840 - 2014-02-26
- [FDA Inspection 564154 - 2009-02-20](https://www.keypedia.com/records/fda_inspections/pharmaceutical-specialties-inc/246d65da-5eb5-47cd-ba92-c5f2e2af7768)

## Related Officers

- [Scott A. Golladay](https://www.keypedia.com/people/scott-a-golladay/78c90066-7212-4442-900c-5cdcb677aeec)

Company: https://www.keypedia.com/companies/pharmaceutical-specialties-inc/21d8b984-d2b5-4f1e-b1c4-0d27eda2ad40

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
